newsfilter
← Latest News
GlobeNewswire·

SELLAS Life Sciences to be Added to Russell 3000® and Russell 2000® Indexes

NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS" or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a